West Pharmaceutical Services, Inc. logo
WSTWest Pharmaceutical Services, Inc.

Shares Outstanding: 72.40M

The shares outstanding is 72.40M. It is below its 12-month average by 0.44% (72.72M).

Shares Outstanding

WST Shares Outstanding

72.40M

Reported quarterly weighted average share count; no daily interpolation.

-4.36% 5Y
WST Shares Outstanding

WST Average Shares Outstanding Chart

WST Shares Outstanding

WST Current vs Average Shares Outstanding Chart

WST Shares Outstanding Metrics

SHARES OUTSTANDING

72.40M

SHARES OUTSTANDING AVG TTM

72.72M

SHARES OUTSTANDING AVG 3Y

73.85M

SHARES OUTSTANDING AVG 5Y

74.62M

SHARES OUTSTANDING AVG 10Y

75.36M

SHARES OUTSTANDING AVG 15Y

74.30M

SHARES OUTSTANDING AVG 20Y

73.83M

CURRENT VS TTM AVG

-0.44%

CURRENT VS 3Y AVG

-1.97%

CURRENT VS 5Y AVG

-2.98%

CURRENT VS 10Y AVG

-3.93%

CURRENT VS 15Y AVG

-2.56%

CURRENT VS 20Y AVG

-1.93%

Share Structure

Shares Outstanding

72.30M

Float Shares

N/A

Stock Price

$350.85

Market Cap

$24.8B

Quarterly Shares Outstanding History

PeriodWeighted Average SharesQoQ Change
Q1 202672.40M-0.41%
Q4 202572.70M+0.00%
Q3 202572.70M-0.14%
Q2 202572.80M-0.27%
Q1 202573.00M-0.95%
Q4 202473.70M+0.41%
Q3 202473.40M-0.41%
Q2 202473.70M-0.81%
Q1 202474.30M-0.93%
Q4 202375.00M-0.40%
Q3 202375.30M-0.13%
Q2 202375.40M-0.40%
Q1 202375.70M+0.13%
Q4 202275.60M-0.13%
Q3 202275.70M-0.13%
Q2 202275.80M-0.26%
Q1 202276.00M-0.52%
Q4 202176.40M+0.53%
Q3 202176.00M+0.40%
Q2 202175.70M-0.13%
Q1 202175.80M-0.39%
Q4 202076.10M+0.40%
Q3 202075.80M+0.40%
Q2 202075.50M+0.00%
Q1 202075.50M-0.26%
Q4 201975.70M+0.26%
Q3 201975.50M+0.53%
Q2 201975.10M-0.27%
Q1 201975.30M-0.26%
Q4 201875.50M-0.26%
Q3 201875.70M+0.93%
Q2 201875.00M-0.66%
Q1 201875.50M-0.53%
Q4 201775.90M+0.00%
Q3 201775.90M+0.13%
Q2 201775.80M+1.20%
Q1 201774.90M+0.00%
Q4 201674.90M-0.13%
Q3 201675.00M+0.27%
Q2 201674.80M+0.94%
Q1 201674.10M+0.00%
Q4 201574.10M+0.27%
Q3 201573.90M+0.27%
Q2 201573.70M+0.55%
Q1 201573.30M+0.14%
Q4 201473.20M+0.83%
Q3 201472.60M+0.28%
Q2 201472.40M+0.14%
Q1 201472.30M+0.14%
Q4 201372.20M+1.12%
Q3 201371.40M+0.85%
Q2 201370.80M+0.85%
Q1 201370.20M+0.29%
Q4 201270.00M+0.86%
Q3 201269.40M-5.19%
Q2 201273.20M-1.35%
Q1 201274.20M+0.00%
Q4 201174.20M+0.27%
Q3 201174.00M+0.00%
Q2 201174.00M+0.54%
Q1 201173.60M+0.00%
Q4 201073.60M+0.27%
Q3 201073.40M+0.00%
Q2 201073.40M+0.55%
Q1 201073.00M+0.00%
Q4 200973.00M+0.27%
Q3 200972.80M+0.55%
Q2 200972.40M+0.28%
Q1 200972.20M+0.00%
Q4 200872.20M-0.28%
Q3 200872.40M-0.28%
Q2 200872.60M+0.55%
Q1 200872.20M+0.00%
Q4 200772.20M-1.90%
Q3 200773.60M-0.81%
Q2 200774.20M+7.54%
Q1 200769.00M+0.00%
Q4 200669.00M+2.07%
Q3 200667.60M+0.72%
Q2 200667.12M+1.38%
Q1 200666.20M-0.08%
Q4 200566.25M+1.06%
Q3 200565.55M+1.93%
Q2 200564.31M+1.20%
Q1 200563.55M+0.00%
Q4 200463.55M+1.61%
Q3 200462.54M+1.85%
Q2 200461.41M+1.89%
Q1 200460.27M+0.00%
Q4 200360.27M+3.21%
Q3 200358.40M+0.80%
Q2 200357.93M+0.02%
Q1 200357.92M+0.00%
Q4 200257.92M+0.12%
Q3 200257.85M-0.30%
Q2 200258.03M-

Relationship: Market Cap = Shares Outstanding × Stock Price

Key concepts:

  • Float shares: Shares available for public trading
  • Dilution: When new shares are issued, existing shareholders own less
  • Buybacks: Reduce share count, increasing EPS and ownership stake
  • Stock splits: Increase share count but don't change market cap

Shares Outstanding Formula & Definition

Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Shares Outstanding FAQ

What is the shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The shares outstanding for WST stock is 72.40M.
What is the TTM average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The TTM average shares outstanding for WST stock is 72.72M.
What is the 3Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The 3Y average shares outstanding for WST stock is 73.85M.
What is the 5Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The 5Y average shares outstanding for WST stock is 74.62M.
What is the 10Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The 10Y average shares outstanding for WST stock is 75.36M.
What is the 15Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The 15Y average shares outstanding for WST stock is 74.30M.
What is the 20Y average shares outstanding for West Pharmaceutical Services, Inc. (WST)?
The 20Y average shares outstanding for WST stock is 73.83M.

WST Shares Outstanding History

DATESHARES OUTSTANDING
2026-03-3172.40M
2025-12-3172.70M
2025-09-3072.70M
2025-06-3072.80M
2025-03-3173.00M
2024-12-3173.70M
2024-09-3073.40M
2024-06-3073.70M
2024-03-3174.30M
2023-12-3175.00M
2023-09-3075.30M
2023-06-3075.40M
2023-03-3175.70M
2022-12-3175.60M
2022-09-3075.70M
2022-06-3075.80M
2022-03-3176.00M
2021-12-3176.40M
2021-09-3076.00M
2021-06-3075.70M
2021-03-3175.80M
2020-12-3176.10M
2020-09-3075.80M
2020-06-3075.50M
2020-03-3175.50M
2019-12-3175.70M
2019-09-3075.50M
2019-06-3075.10M
2019-03-3175.30M
2018-12-3175.50M
2018-09-3075.70M
2018-06-3075.00M
2018-03-3175.50M
2017-12-3175.90M
2017-09-3075.90M
2017-06-3075.80M
2017-03-3174.90M
2016-12-3174.90M
2016-09-3075.00M
2016-06-3074.80M
2016-03-3174.10M
2015-12-3174.10M
2015-09-3073.90M
2015-06-3073.70M
2015-03-3173.30M
2014-12-3173.20M
2014-09-3072.60M
2014-06-3072.40M
2014-03-3172.30M
2013-12-3172.20M
2013-09-3071.40M
2013-06-3070.80M
2013-03-3170.20M
2012-12-3170.00M
2012-09-3069.40M
2012-06-3073.20M
2012-03-3174.20M
2011-12-3174.20M
2011-09-3074.00M
2011-06-3074.00M
2011-03-3173.60M
2010-12-3173.60M
2010-09-3073.40M
2010-06-3073.40M
2010-03-3173.00M
2009-12-3173.00M
2009-09-3072.80M
2009-06-3072.40M
2009-03-3172.20M
2008-12-3172.20M
2008-09-3072.40M
2008-08-0572.60M
2008-03-3172.20M
2007-12-3172.20M
2007-09-3073.60M
2007-06-3074.20M
2007-03-3169.00M
2006-12-3169.00M
2006-09-3067.60M
2006-06-3067.12M
2006-03-3166.20M
2005-12-3166.25M
2005-09-3065.55M
2005-06-3064.31M
2005-03-3163.55M
2004-12-3163.55M
2004-09-3062.54M
2004-06-3061.41M
2004-03-3160.27M
2003-12-3160.27M
2003-09-3058.40M
2003-06-3057.93M
2003-03-3157.92M
2002-12-3157.92M
2002-09-3057.85M
2002-06-3058.03M

About West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) specializes in the development, manufacturing, and global distribution of essential containment and delivery solutions for injectable pharmaceuticals and other healthcare products. The company's operations span across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region, structured into two primary business units: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers a comprehensive array of components for injectable packaging, including stoppers and seals, alongside syringe and cartridge parts, which can be customized for specific injectable drug delivery requirements. It also provides advanced drug administration systems designed to enhance safe and effective delivery through sophisticated reconstitution, mixing, and transfer technologies. This segment further supplies ancillary services such as specialized films, protective coatings, cleaning, precision vision inspection, and sterilization processes to elevate the quality of packaging components. Innovative drug containment options, like Crystal Zenith – a cyclic olefin polymer used in vials, syringes, and cartridges – and user-friendly self-injection devices are also key offerings. Additionally, it provides a suite of integrated support services covering analytical laboratory analysis, primary packaging assistance during the pre-approval stage, engineering development, regulatory guidance, and post-purchase technical support. Its clientele primarily includes manufacturers of biologic, generic, and other pharmaceutical products. In contrast, the Contract-Manufactured Products division focuses on the design, production, and automated assembly of various devices for surgical, diagnostic, ophthalmic, and general drug delivery applications, alongside consumer items. This segment caters to pharmaceutical, diagnostic, and medical device manufacturers. The company's offerings reach customers worldwide through a dedicated sales team, an extensive distribution network, and partnerships with contract sales agents and regional distributors. Established in 1923, West Pharmaceutical Services, Inc. is headquartered in Exton, Pennsylvania.

Exton, PA
10,600 employees
Healthcare / Medical - Instruments & Supplies
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Eric Green